Nirup Krishnamurthy - Medicine Man Director COO
| SHWZ Stock | USD 0.10 0.01 9.09% |
Insider
Nirup Krishnamurthy is Director COO of Medicine Man Technologies
| Age | 60 |
| Phone | 303 371 0387 |
| Web | https://www.schwazze.com |
Medicine Man Management Efficiency
The company has return on total asset (ROA) of 0.0452 % which means that it generated a profit of $0.0452 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1569 %, meaning that it created $0.1569 on every $100 dollars invested by stockholders. Medicine Man's management efficiency ratios could be used to measure how well Medicine Man manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
| CCFP DipSportMed | Evolus Inc | 60 | |
| Rami Levy | INC Research Holdings | 59 | |
| Richard MD | Collegium Pharmaceutical | 64 | |
| Muthusamy RPh | ANI Pharmaceuticals | 56 | |
| BComm BCom | Akanda Corp | 68 | |
| Sibyl Swift | cbdMD Inc | 43 | |
| Tejinder Virk | Akanda Corp | 42 | |
| Advocate Ohayon | INC Research Holdings | 35 | |
| Kevin MacDermott | cbdMD Inc | 62 | |
| OriMoni Mimon | INC Research Holdings | 36 | |
| BCom BAcc | Akanda Corp | 44 | |
| Mark Baldyga | Biofrontera | N/A | |
| Marlo Manning | Collegium Pharmaceutical | N/A | |
| Erica CPA | Biofrontera | 39 | |
| Sandra Beaver | Evolus Inc | 46 | |
| Hermann Lubbert | Biofrontera | 68 | |
| Thomas Flow | Akanda Corp | 46 | |
| John Weston | cbdMD Inc | N/A | |
| Amos Cohen | INC Research Holdings | 45 | |
| Matthew Coapman | cbdMD Inc | 48 | |
Management Performance
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0452 |
Medicine Man Technologies Leadership Team
Elected by the shareholders, the Medicine Man's board of directors comprises two types of representatives: Medicine Man inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medicine. The board's role is to monitor Medicine Man's management team and ensure that shareholders' interests are well served. Medicine Man's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medicine Man's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel Pabon, Chief Counsel | ||
| Jim Parco, Pres Ltd | ||
| Steven Pear, Pres Division | ||
| Ashley Bradley, Director Controller | ||
| Justin Dye, Ex CEO | ||
| Shane Sampson, Chief Officer | ||
| Nirup Krishnamurthy, Director COO | ||
| Nancy Huber, Chief Officer | ||
| Joanne Jobin, Investor Officer | ||
| Lee Dayton, Chief Officer |
Medicine Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Medicine Man a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.0452 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 180.81 M | |||
| Shares Outstanding | 54.74 M | |||
| Shares Owned By Insiders | 26.48 % | |||
| Shares Owned By Institutions | 0.73 % | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 0.49 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medicine Pink Sheet Analysis
When running Medicine Man's price analysis, check to measure Medicine Man's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicine Man is operating at the current time. Most of Medicine Man's value examination focuses on studying past and present price action to predict the probability of Medicine Man's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicine Man's price. Additionally, you may evaluate how the addition of Medicine Man to your portfolios can decrease your overall portfolio volatility.